Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Inflammatory Bowel Diseases

Free Subscription Articles published in Gastroenterology Retrieve available abstracts of 152 articles: HTML format

Single Articles

November 2025
1. MARAFINI I, Salvatori S, Troncone E, Monteleone G, et al
   CD19 CAR T-Cell therapy for refractory ulcerative colitis.
   Gastroenterology. 2025 Nov 18:S0016-5085(25)06527.
   PubMed    
   
   
   
2. GETTLER K, Nagpal S, Washburn S, Tastad C, et al
   Postoperative Ileum Transcriptomics Implicate Sex-Biased Mechanisms in Crohn's Disease Recurrence.
   Gastroenterology. 2025 Nov 18:S0016-5085(25)05983.
   PubMed     Abstract available
   
   
   
3. SHANG A, Wang W, Zhao K
   Artificial Intelligence in Inflammatory Bowel Disease Management.
   Gastroenterology. 2025 Nov 15:S0016-5085(25)06035.
   PubMed    
   
   
   
4. BERNSTEIN CN, Gearry R, Nugent Z, Witt J, et al
   Global Discrepancies in Inflammatory Bowel Disease Care Reflect Health Care Expenditure Per Capita.
   Gastroenterology. 2025 Nov 14:S0016-5085(25)05902.
   PubMed    
   
   
   
5. KUCHARZIK T, Allocca M, Torres J, Taylor SA, et al
   Role of Noninvasive Imaging in the Diagnosis and Management of Patients With Suspected and Established Inflammatory Bowel Disease.
   Gastroenterology. 2025;169:1166-1183.
   PubMed     Abstract available
   
   
   October 2025
6. TIAN Z, Huang Y
   Improving Precision in Crohn's Disease: Insights from the VCE Trial.
   Gastroenterology. 2025 Oct 29:S0016-5085(25)05894.
   PubMed    
   
   
   
7. FAN Q, Li M
   Critical Role of Fucosyltransferase VII in Glycosylation-Dependent Regulatory T Cell Function in Inflammatory Bowel Disease.
   Gastroenterology. 2025 Oct 21:S0016-5085(25)06141.
   PubMed    
   
   
   
8. SINGH S, Murad MH, Yuan Y, Ananthakrishnan AN, et al
   Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Crohn's Disease: 2025 AGA Evidence Synthesis.
   Gastroenterology. 2025 Oct 20:S0016-5085(25)05964.
   PubMed     Abstract available
   
   
   
9. DAI C, Huang YH
   Advancing Quiescent Crohn's Disease Management: Capsule Endoscopy-Guided Treat-to-Target Strategy or Standard Care?
   Gastroenterology. 2025 Oct 18:S0016-5085(25)05893.
   PubMed    
   
   
   
10. WANG H, Xue K, Kong Y, Shen X, et al
    GRAVITI Study on Guselkumab's Efficacy and Safety for Moderate to Severe Crohn's Disease.
    Gastroenterology. 2025 Oct 10:S0016-5085(25)06110.
    PubMed    
    
    
    
11. XU J, Gao Y, Zhang Y
    Subcutaneous IL-23 Blockade as a Patient-Centered Strategy in Crohn's Disease.
    Gastroenterology. 2025 Oct 10:S0016-5085(25)06111.
    PubMed    
    
    
    
12. LIU J, Shi Y, Yang Y
    Reevaluating the GRAVITI Trial of Subcutaneous Guselkumab for Crohn's Disease.
    Gastroenterology. 2025 Oct 10:S0016-5085(25)06109.
    PubMed    
    
    
    
13. IRWIN S, van Daelen M, Almaraz I, Park R, et al
    Fidaxomicin Reduces Collagen Expression in Intestinal Fibroblasts Via Platelet-Derived Growth Factor Receptor Beta and Glycogen Synthase Kinase-3 Beta Inhibition.
    Gastroenterology. 2025;169:925-941.
    PubMed     Abstract available
    
    
    
14. BOLTE LA, Bjork JR, Gacesa R, Weersma RK, et al
    Pharmacomicrobiomics: The Role of the Gut Microbiome in Immunomodulation and Cancer Therapy.
    Gastroenterology. 2025;169:813-827.
    PubMed     Abstract available
    
    
    September 2025
15. VAN LIEROP LMA, Devillers MJC, van der Woude CJ, Hoentjen F, et al
    Long-term outcomes of increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission: 3-year follow-up of the randomized controlled LADI trial.
    Gastroenterology. 2025 Sep 19:S0016-5085(25)06024.
    PubMed    
    
    
    August 2025
16. MOULI VP, Kedia S, Sharma V, Pulimood AB, et al
    Navigating the Differential Diagnosis of Intestinal Tuberculosis and Crohn's Disease.
    Gastroenterology. 2025 Aug 19:S0016-5085(25)05883.
    PubMed    
    
    
    
17. KHANNA R, Kuenzig ME
    Global Incidence and Prevalence of Inflammatory Bowel Disease Over Time.
    Gastroenterology. 2025 Aug 5:S0016-5085(25)05854.
    PubMed    
    
    
    
18. HUANG S, Pan L, Pang S, Guo H, et al
    Perforin Generated by CD8(+) T Cells Exacerbates Inflammatory Bowel Disease-Induced Depression by Promoting CXCL9 Production in Intestinal Epithelial Cells.
    Gastroenterology. 2025;169:294-307.
    PubMed     Abstract available
    
    
    
19. STIDHAM RW, Ghanem LR, Fletcher JG, Bruining DH, et al
    Artificial Intelligence-Enabled Clinical Trials in Inflammatory Bowel Disease: Automating and Enhancing Disease Assessment and Study Management.
    Gastroenterology. 2025;169:432-443.
    PubMed     Abstract available
    
    
    July 2025
20. LI WAI SUEN CFD, Choy MC, Con D, Cheng K, et al
    Early infliximab levels and clearance predict outcomes after infliximab rescue in acute severe ulcerative colitis: Results from PREDICT-UC.
    Gastroenterology. 2025 Jul 21:S0016-5085(25)05777.
    PubMed     Abstract available
    
    
    
21. BOURGONJE AR, Ibing S, Rajauria P, Peraza J, et al
    Mild Crohn's Disease is Associated with Altered Sphingolipid Metabolism and Reduced Neutrophilic Inflammation.
    Gastroenterology. 2025 Jul 7:S0016-5085(25)05731.
    PubMed    
    
    
    
22. REZAZADEH ARDABILI A, Polydorides AD, Colombel JF
    Scrotal swelling in a patient with Crohn's disease: More than meets the eye.
    Gastroenterology. 2025 Jul 2:S0016-5085(25)05728.
    PubMed    
    
    
    June 2025
23. BEMELMAN WA, Haanappel AEG, Duijvestein M, van der Does de Willebois EML, et al
    Comments on "Postoperative Endoscopic Outcomes in the MESOCOLIC Trial Investigating Mesenteric-Based Surgery for Crohn's Disease".
    Gastroenterology. 2025 Jun 30:S0016-5085(25)00955.
    PubMed    
    
    
    
24. LIU D, Wei Y, Wan J
    Exploring the Role of Wearable Devices in Inflammatory Bowel Disease Management.
    Gastroenterology. 2025 Jun 25:S0016-5085(25)00906.
    PubMed    
    
    
    
25. WANG P, Wang J, Zhang P, Xiao W, et al
    Comments on "Preclinical protein signatures of Crohn's disease and ulcerative colitis: A nested case-control study within large population-based cohorts".
    Gastroenterology. 2025 Jun 23:S0016-5085(25)00903.
    PubMed    
    
    
    
26. FRUTKOFF YA, Plotkin L, Pollak D, Livovsky J, et al
    Whole food diet induces remission in children and young adults with mild-moderate Crohn's disease and is more tolerable than exclusive enteral nutrition: a randomized controlled trial.
    Gastroenterology. 2025 Jun 17:S0016-5085(25)00896.
    PubMed     Abstract available
    
    
    May 2025
27. HANZEL J, Solitano V, Vuyyuru SK, Panaccione R, et al
    An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease.
    Gastroenterology. 2025 May 28:S0016-5085(25)00825.
    PubMed     Abstract available
    
    
    
28. ZHANG Y, Ran Q, Tang X, Wang Y, et al
    Creeping Fat and Muscle Hyperplasia in Crohn's Disease: A Critical Mechanistic Link for Stricture Formation.
    Gastroenterology. 2025 May 2:S0016-5085(25)00665.
    PubMed    
    
    
    
29. KELM M, Flemming S
    The importance of the mesentery in the pathophysiology of Crohn's disease.
    Gastroenterology. 2025 May 2:S0016-5085(25)00664.
    PubMed    
    
    
    April 2025
30. WU X, Li Y, Li P, Lu G, et al
    Structural variations in ulcerative colitis-associated E. coli reduce fructose utilization and aggravate inflammation under high fructose diet.
    Gastroenterology. 2025 Apr 16:S0016-5085(25)00635.
    PubMed     Abstract available
    
    
    
31. ALLOCCA M, Falloon K, Danese S, Rieder F, et al
    Monitoring the calm before the storm - A video capsule endoscopy guided proactive treat-to-target approach in Crohn's disease.
    Gastroenterology. 2025 Apr 10:S0016-5085(25)00631.
    PubMed    
    
    
    
32. MENGHINI P, Butto LF, Gomez-Nguyen A, Aladyshkina N, et al
    TL1A/DR3 signaling regulates the generation of pathogenic Th9 cells in experimental Crohn's disease.
    Gastroenterology. 2025 Apr 7:S0016-5085(25)00606.
    PubMed     Abstract available
    
    
    
33. LIU K, Chen B, Lin X, Zhou Q, et al
    alpha1,3 Fucosyltransferase VII Improves Intestinal Immune Homeostasis in Inflammatory Bowel Disease by Enhancing Regulatory T-Cell Intestinal Homing and Immunosuppression.
    Gastroenterology. 2025 Apr 1:S0016-5085(25)00586.
    PubMed     Abstract available
    
    
    March 2025
34. LI L
    Impact of Parental Crohn's Disease on Offspring's Gut Health and Disease Vulnerability.
    Gastroenterology. 2025 Mar 31:S0016-5085(25)00588.
    PubMed    
    
    
    
35. TANG L
    Comments on "Multimodal Profiling of Peripheral Blood Identifies Proliferating Circulating Effector CD4+ T Cells as Predictors for Response to Integrin alpha4beta7-Blocking Therapy in Inflammatory Bowel Disease".
    Gastroenterology. 2025 Mar 28:S0016-5085(25)00545.
    PubMed    
    
    
    
36. NARVEY S, Ghia JE, Marrie RA, Armstrong H, et al
    Heavy Metals and Inflammatory Bowel Disease.
    Gastroenterology. 2025 Mar 27:S0016-5085(25)00540.
    PubMed    
    
    
    
37. PRENTICE RE, Flanagan EK, Wright EK, Dolinger MT, et al
    Active inflammatory bowel disease on intestinal ultrasound during pregnancy is associated with an increased risk of adverse pregnancy and neonatal outcomes independent of clinical and biochemical disease activity.
    Gastroenterology. 2025 Mar 25:S0016-5085(25)00537.
    PubMed     Abstract available
    
    
    
38. MCDONALD BD, Choi NK, Klein JA, St-Pierre J, et al
    Clinical trials for perianal Crohn's disease: A call for a revised approach.
    Gastroenterology. 2025 Mar 20:S0016-5085(25)00529.
    PubMed    
    
    
    
39. HART A, Panaccione R, Steinwurz F, Danese S, et al
    Efficacy and Safety of Guselkumab Subcutaneous Induction and Maintenance in Participants with Moderately to Severely Active Crohn's Disease: Results from the Phase 3 GRAVITI Study.
    Gastroenterology. 2025 Mar 18:S0016-5085(25)00522.
    PubMed     Abstract available
    
    
    
40. BEN-HORIN S, Lahat A, Ungar B, Ukashi O, et al
    Capsule endoscopy-guided proactive treat-to-target versus continued standard care in patients with quiescent Crohn's disease: A randomized controlled trial.
    Gastroenterology. 2025 Mar 13:S0016-5085(25)00519.
    PubMed     Abstract available
    
    
    
41. IACUCCI M, Santacroce G, Maeda Y, Ghosh S, et al
    AI-driven Personalized Medicine: Transforming Clinical Practice in Inflammatory Bowel Disease.
    Gastroenterology. 2025 Mar 10:S0016-5085(25)00494.
    PubMed     Abstract available
    
    
    
42. WANG Y, Zhang C
    Expand Research in Risk of Developing Crohn's Disease.
    Gastroenterology. 2025 Mar 6:S0016-5085(25)00490.
    PubMed    
    
    
    
43. YANG X, Hu Q
    Comments on "Healthy first-degree relatives from multiplex families versus simplex families have a higher subclinical intestinal inflammation, a distinct fecal microbial signature, and harbor a higher risk of developing Crohn's disease".
    Gastroenterology. 2025 Mar 6:S0016-5085(25)00489.
    PubMed    
    
    
    February 2025
44. NANDY A, Petralia F, Porter C, Elledge S, et al
    Epstein-Barr Virus (EBV) Exposure Precedes Crohn;s Disease Development.
    Gastroenterology. 2025 Feb 21:S0016-5085(25)00411.
    PubMed    
    
    
    
45. ABREU MT, Devkota S, Issokson K
    A Mediterranean diet for Crohn's disease: Embracing colorful diversity to improve the microbiome.
    Gastroenterology. 2025 Feb 14:S0016-5085(25)00366.
    PubMed    
    
    
    
46. MA C
    Mirikizumab for Crohn's Disease: Small Step Forward or Giant Leap Ahead?
    Gastroenterology. 2025 Feb 4:S0016-5085(25)00344.
    PubMed    
    
    
    
47. TURPIN W, Lee SH, Croitoru K
    Gut Microbiome Signature in Predisease Phase of Inflammatory Bowel Disease: Prediction to Pathogenesis to Prevention.
    Gastroenterology. 2025 Feb 3:S0016-5085(25)00039.
    PubMed     Abstract available
    
    
    January 2025
48. KHANNA R
    The safety and efficacy of guselkumab for the treatment of moderate to severely active ulcerative colitis.
    Gastroenterology. 2025 Jan 31:S0016-5085(25)00333.
    PubMed    
    
    
    
49. OWEN C, Shen L, Cardoso A, Lichenstein G, et al
    Comments on biologic ranking methodology used by the network meta-analysis to inform the 2024 ulcerative colitis guideline.
    Gastroenterology. 2025 Jan 25:S0016-5085(25)00062.
    PubMed    
    
    
    
50. LI L
    Pouch Crohn's-like Disease: Mucosal Single-Cell Profiling Uncovers Pathogenesis and Targets.
    Gastroenterology. 2025 Jan 17:S0016-5085(25)00045.
    PubMed    
    
    
    
51. GODNY L, Elial-Fatal S, Arrouasse J, Sharar Fischler T, et al
    Mechanistic implications of the Mediterranean diet in patients with newly diagnosed Crohn's disease- multi-omic results from a prospective cohort.
    Gastroenterology. 2025 Jan 13:S0016-5085(25)00038.
    PubMed     Abstract available
    
    
    
52. DUAN M, Liu W, Coffey JC, Ke J, et al
    Postoperative Endoscopic Outcomes in the MESOCOLIC Trial Investigating Mesenteric-based surgery for Crohn's Disease.
    Gastroenterology. 2025 Jan 9:S0016-5085(25)00017.
    PubMed    
    
    
    
53. HIRTEN RP, Danieletto M, Sanchez-Mayor M, Whang JK, et al
    Physiological Data Collected from Wearable Devices Identify and Predict Inflammatory Bowel Disease Flares.
    Gastroenterology. 2025 Jan 9:S0016-5085(25)00013.
    PubMed     Abstract available
    
    
    December 2024
54. COFFEY JC, Bai L, Wu FF
    Catching up with creeping fat - unravelling the mysteries of the mesentery in Crohn's disease.
    Gastroenterology. 2024 Dec 24:S0016-5085(24)05805.
    PubMed    
    
    
    
55. LI L
    Comments on "Inflammatory markers at birth and risk of early onset inflammatory bowel disease".
    Gastroenterology. 2024 Dec 20:S0016-5085(24)05797.
    PubMed    
    
    
    
56. SHAO X, Chen J, Zhu C, Li J, et al
    Analysis of "Inflammatory Markers at Birth and Risk of Early-Onset Inflammatory Bowel Disease".
    Gastroenterology. 2024 Dec 20:S0016-5085(24)05795.
    PubMed    
    
    
    
57. MAO XY, Yang YY, Tian L
    A win-win solution: remarkable reversal of foot necrosis in ulcerative colitis.
    Gastroenterology. 2024 Dec 7:S0016-5085(24)05784.
    PubMed    
    
    
    
58. SINGH S, Loftus EV Jr, Limketkai BN, Haydek JP, et al
    AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis.
    Gastroenterology. 2024;167:1307-1343.
    PubMed     Abstract available
    
    
    
59. DI VINCENZO F, Quintero MA, Mendygral P, Abreu MT, et al
    Gender Inequity in Pharma-Supported Inflammatory Bowel Disease Presentations: Shining a Light on Opportunities for Equality and Transparency in Medical Research.
    Gastroenterology. 2024;167:1256-1259.
    PubMed    
    
    
    
60. ZHAO Q, Duck LW, Killian JT Jr, Rosenberg AF, et al
    Crohn's Patients and Healthy Infants Share Immunodominant B Cell Response to Commensal Flagellin Peptide Epitopes.
    Gastroenterology. 2024;167:1415-1428.
    PubMed     Abstract available
    
    
    November 2024
61. GRANNO O, Bergemalm D, Salomon B, Lindqvist CM, et al
    Preclinical protein signatures of Crohn's disease and ulcerative colitis: A nested case-control study within large population-based cohorts.
    Gastroenterology. 2024 Nov 21:S0016-5085(24)05741.
    PubMed     Abstract available
    
    
    
62. KAPPELMAN MD, Brensinger C, Parlett LE, Hurtado-Lorenzo A, et al
    Prevalence of Pediatric Inflammatory Bowel Disease in the United States: Pooled Estimates from Three Administrative Claims Data Sources.
    Gastroenterology. 2024 Nov 16:S0016-5085(24)05698.
    PubMed    
    
    
    
63. AGRAWAL M, Ungaro RC, Rajauria P, Magee J, et al
    High serum pesticide levels are associated with increased odds of inflammatory bowel disease in a nested case-control study.
    Gastroenterology. 2024 Nov 9:S0016-5085(24)05692.
    PubMed    
    
    
    
64. LIU W, Mao R, Nga Le TH, West G, et al
    CREEPING FAT-DERIVED FREE FATTY ACIDS INDUCE HYPERPLASIA OF INTESTINAL MUSCULARIS PROPRIA MUSCLE CELLS - A NOVEL LINK BETWEEN FAT AND INTESTINAL STRICTURE FORMATION IN CROHN'S DISEASE.
    Gastroenterology. 2024 Nov 8:S0016-5085(24)05659.
    PubMed     Abstract available
    
    
    
65. DORNER H, Stolzer I, Mattner J, Kaminski S, et al
    Gut Pathobiont-Derived Outer Membrane Vesicles Drive Liver Inflammation and Fibrosis in Primary Sclerosing Cholangitis-Associated Inflammatory Bowel Disease.
    Gastroenterology. 2024;167:1183-1197.
    PubMed     Abstract available
    
    
    October 2024
66. JONES K, Plotkin L, Loukogeorgakis S, Cytter-Kuint R, et al
    The management of internal fistulizing Crohn's disease in a child: more than meets the eye.
    Gastroenterology. 2024 Oct 28:S0016-5085(24)05644.
    PubMed    
    
    
    
67. ANANTHAKRISHNAN AN, Murad MH, Scott FI, Agrawal M, et al
    Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Ulcerative Colitis: 2024 American Gastroenterological Association Evidence Synthesis.
    Gastroenterology. 2024 Oct 18:S0016-5085(24)05480.
    PubMed     Abstract available
    
    
    
68. SOLITANO V, Hogan M, Singh S, Danese S, et al
    Placebo rates in Crohn's disease randomized clinical trials: An individual patient data meta-analysis.
    Gastroenterology. 2024 Oct 14:S0016-5085(24)05571.
    PubMed     Abstract available
    
    
    
69. LEE SH, Bushra M, Qiu L, Griffiths AM, et al
    Early Life Exposure to Parental Crohn's disease is Associated with Offspring's Gut Microbiome, Gut Permeability and Increased Risk of Future Crohn's Disease.
    Gastroenterology. 2024 Oct 7:S0016-5085(24)05539.
    PubMed    
    
    
    
70. CAMILLERI M
    Pouchitis: Is It Time to Think Beyond the Inflammation in the Pouch?
    Gastroenterology. 2024;167:821-825.
    PubMed    
    
    
    September 2024
71. HORN V, Cancino CA, Steinheuer LM, Obermayer B, et al
    Multimodal profiling of peripheral blood identifies proliferating circulating effector CD4(+) T cells as predictors for response to integrin alpha4beta7-blocking therapy in inflammatory bowel disease.
    Gastroenterology. 2024 Sep 27:S0016-5085(24)05527.
    PubMed     Abstract available
    
    
    
72. ROSHANOV PS, Khanna R
    Risankizumab for Induction and Maintenance of Remission in Ulcerative Colitis.
    Gastroenterology. 2024 Sep 7:S0016-5085(24)05444.
    PubMed    
    
    
    
73. ROSHANOV PS, Khanna R
    A Head-to Head Comparison of Risankizumab and Ustekinumab as second line therapy in moderate to severely active Crohn's disease.
    Gastroenterology. 2024 Sep 7:S0016-5085(24)05445.
    PubMed    
    
    
    
74. OLIVERA PA, Martinez-Lozano H, Leibovitzh H, Xue M, et al
    Healthy first-degree relatives from multiplex families versus simplex families have a higher subclinical intestinal inflammation, a distinct fecal microbial signature, and harbor a higher risk of developing Crohn's disease.
    Gastroenterology. 2024 Sep 3:S0016-5085(24)05414.
    PubMed     Abstract available
    
    
    August 2024
75. LU C, Feagan BG, Fletcher JG, Baker M, et al
    Management of Small Bowel Crohn's Disease Strictures: To cut, to stretch or to treat inflammation?
    Gastroenterology. 2024 Aug 31:S0016-5085(24)05413.
    PubMed    
    
    
    
76. LEE SH, Turpin W, Espin-Garcia O, Xu W, et al
    Development and Validation of an Integrative Risk Score for Future Risk of Crohn's Disease in Healthy First-Degree Relatives: A Multicentre Prospective Cohort Study.
    Gastroenterology. 2024 Aug 27:S0016-5085(24)05401.
    PubMed    
    
    
    
77. KAHN-BOESEL O, Araka E, Anyane-Yeboa A, Ufere NN, et al
    The Discrepant Visual Representation of Inflammatory Bowel Diseases in the Internet and Media.
    Gastroenterology. 2024;167:436-440.
    PubMed    
    
    
    
78. LUO X, Wang J, Tan C, Dou Q, et al
    Rapid Endoscopic Diagnosis of Benign Ulcerative Colorectal Diseases With an Artificial Intelligence Contextual Framework.
    Gastroenterology. 2024;167:591-603.
    PubMed     Abstract available
    
    
    July 2024
79. CAO S, Nguyen K, Ma K, Du X, et al
    Mucosal Single-Cell Profiling of Crohn's-Like Disease of the Pouch Reveals Unique Pathogenesis and Therapeutic Targets.
    Gastroenterology. 2024 Jul 29:S0016-5085(24)05284.
    PubMed     Abstract available
    
    
    
80. GAWEY BJ, Kane SV
    Head and Neck Pain in a Patient with Ulcerative Colitis.
    Gastroenterology. 2024 Jul 27:S0016-5085(24)05285.
    PubMed    
    
    
    
81. RUDBAEK JJ, Borbye-Lorenzen N, Poulsen GJ, Koziol A, et al
    Inflammatory markers at birth and risk of early onset inflammatory bowel disease.
    Gastroenterology. 2024 Jul 13:S0016-5085(24)05210.
    PubMed    
    
    
    
82. MULANAX C, Velayos FS
    Shot heard around the world? Subcutaneous Infliximab (CT-P13) as Maintenance Therapy for Inflammatory Bowel Disease.
    Gastroenterology. 2024 Jul 11:S0016-5085(24)05207.
    PubMed    
    
    
    
83. ASHTON JJ, Satsangi J, Uhlig HH
    Intestinal Inflammation and Extraintestinal Disease: Understanding Dynamic Risk.
    Gastroenterology. 2024;167:205-208.
    PubMed    
    
    
    June 2024
84. PEDICELLI A, Michel RP, Sebastiani G
    An Unusual Cause of Acute Liver Failure Diagnosed on Organ Explant in a Patient with Ulcerative Colitis.
    Gastroenterology. 2024 Jun 29:S0016-5085(24)05174.
    PubMed    
    
    
    
85. BOURGONJE AR, Ungaro RC, Mehandru S, Colombel JF, et al
    Targeting the IL-23 Pathway in Inflammatory Bowel Disease.
    Gastroenterology. 2024 Jun 28:S0016-5085(24)05124.
    PubMed     Abstract available
    
    
    May 2024
86. HANAUER SB, Sands BE, Schreiber S, Danese S, et al
    Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials.
    Gastroenterology. 2024 May 22:S0016-5085(24)04918.
    PubMed     Abstract available
    
    
    
87. LUJAN R, Buchuk R, Focht G, Yogev D, et al
    Early Initiation of Biologics and Disease Outcomes in Adults and Children With Inflammatory Bowel Diseases: Results From the Epidemiology Group of the Nationwide Israeli Inflammatory Bowel Disease Research Nucleus Cohort.
    Gastroenterology. 2024;166:815-825.
    PubMed     Abstract available
    
    
    
88. BAMIDELE AO, Mishra SK, Piovezani Ramos G, Hirsova P, et al
    Interleukin 21 Drives a Hypermetabolic State and CD4(+) T-Cell-Associated Pathogenicity in Chronic Intestinal Inflammation.
    Gastroenterology. 2024;166:826-841.
    PubMed     Abstract available
    
    
    April 2024
89. HONAP S, Sands BE, Jairath V, Danese S, et al
    Basket, Umbrella, and Platform Trials: The Potential for Master Protocol -Based Trials in Inflammatory Bowel Disease.
    Gastroenterology. 2024 Apr 25:S0016-5085(24)00485.
    PubMed    
    
    
    
90. KEEFER L, Hashash JG, Szigethy E, Mayer EA, et al
    AGA Clinical Practice Update on Pain Management in Inflammatory Bowel Disease: Commentary.
    Gastroenterology. 2024 Apr 17:S0016-5085(24)00358.
    PubMed     Abstract available
    
    
    
91. ZOLLNER A, Koch R, Jukic A, Pfister A, et al
    Clearance of gut mucosal SARS-CoV-2 antigens and post-acute COVID-19 after two years in patients with inflammatory bowel disease.
    Gastroenterology. 2024 Apr 15:S0016-5085(24)00423.
    PubMed    
    
    
    March 2024
92. IACUCCI M, Maeda Y, Ghosh S
    A Baby Step or a Real Giant Stride: Histomic Enabled by Artificial Intelligence to Predict Treatment Response in Pediatric Patients with Ulcerative Colitis.
    Gastroenterology. 2024 Mar 7:S0016-5085(24)00284.
    PubMed    
    
    
    
93. ZINGONE F, Bai JC, Cellier C, Ludvigsson JF, et al
    Celiac disease-related conditions: Who to test?
    Gastroenterology. 2024 Mar 7:S0016-5085(24)00282.
    PubMed     Abstract available
    
    
    
94. MITEV S, Marinova C, Spassova Z
    A colorful conundrum: dark urine in a patient with inflammatory bowel disease.
    Gastroenterology. 2024 Mar 5:S0016-5085(24)00249.
    PubMed    
    
    
    
95. PEERY AF, Kelly CR, Kao D, Vaughn BP, et al
    AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases.
    Gastroenterology. 2024;166:409-434.
    PubMed     Abstract available
    
    
    
96. DULAI PS, Singh S, Jairath V, Wong E, et al
    Integrating Evidence to Guide Use of Biologics and Small Molecules for Inflammatory Bowel Diseases.
    Gastroenterology. 2024;166:396-408.
    PubMed     Abstract available
    
    
    February 2024
97. KHROM M, Long M, Dube S, Robbins L, et al
    Comprehensive association analyses of extraintestinal manifestations in inflammatory bowel disease.
    Gastroenterology. 2024 Feb 27:S0016-5085(24)00232.
    PubMed     Abstract available
    
    
    
98. HERAUF M, Coward S, Pena-Sanchez JN, Bernstein CN, et al
    A Commentary on the Epidemiology of Inflammatory Bowel Disease in Compounding Prevalence Nations: Towards Sustaining Healthcare Delivery.
    Gastroenterology. 2024 Feb 18:S0016-5085(24)00178.
    PubMed    
    
    
    
99. MARILD K, Soderling J, Stephansson O, Axelrad J, et al
    Histological remission in inflammatory bowel disease and female fertility: A nationwide study.
    Gastroenterology. 2024 Feb 6:S0016-5085(24)00055.
    PubMed     Abstract available
    
    
    
100. KOCHAR B, Ananthakrishnan AN, Ritchie CS
     Pharmacoequity for Older Adults With Inflammatory Bowel Diseases.
     Gastroenterology. 2024;166:235-239.
     PubMed    
     
     
     
101. HE S, Peng Y, Wei Q
     Comments on "Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study".
     Gastroenterology. 2024;166:356-357.
     PubMed    
     
     
     
102. LIU X, Prasath S, Siddiqui I, Walters TD, et al
     Machine Learning-Based Prediction of Pediatric Ulcerative Colitis Treatment Response using Diagnostic Histopathology.
     Gastroenterology. 2024 Feb 1:S0016-5085(24)00119.
     PubMed    
     
     
     January 2024
103. HASHASH JG, Elkins J, Lewis JD, Binion DG, et al
     AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review.
     Gastroenterology. 2024 Jan 23:S0016-5085(23)05597.
     PubMed     Abstract available
     
     
     
104. KOSINSKY RL, Gonzalez MM, Saul D, Barros LL, et al
     The FOXP3(+) Pro-inflammatory T cell: A Potential Therapeutic Target in Crohn's Disease.
     Gastroenterology. 2024 Jan 9:S0016-5085(24)00009.
     PubMed     Abstract available
     
     
     
105. BARNES EL, Agrawal M, Syal G, Ananthakrishnan AN, et al
     AGA Clinical Practice Guideline on the Management of Pouchitis and Inflammatory Pouch Disorders.
     Gastroenterology. 2024;166:59-85.
     PubMed     Abstract available
     
     
     
106. GILLILAND A, Chan JJ, De Wolfe TJ, Yang H, et al
     Pathobionts in Inflammatory Bowel Disease: Origins, Underlying Mechanisms, and Implications for Clinical Care.
     Gastroenterology. 2024;166:44-58.
     PubMed     Abstract available
     
     
     
107. EQUINOZZI E, O'Donnell M, Lee CD
     A Woman With Pyoderma Gangrenosum, Recurrent Abdominal Pain, and Hematochezia.
     Gastroenterology. 2024;166:31-35.
     PubMed    
     
     
     
108. SHEN X, Zhang Q, Zhang B
     A 16-Year-Old Onset Case of Pancolitis With Rectovaginal and Rectovesical Fistulas.
     Gastroenterology. 2024;166:e1-e5.
     PubMed    
     
     
     December 2023
109. CAENEPEEL C, Falony G, Machiels K, Verstockt B, et al
     Dysbiosis and associated stool features improve prediction of response to biological therapy in inflammatory bowel disease.
     Gastroenterology. 2023 Dec 12:S0016-5085(23)05598.
     PubMed     Abstract available
     
     
     
110. ANANTHAKRISHNAN AN, Adler J, Chachu KA, Nguyen NH, et al
     AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Crohn's Disease.
     Gastroenterology. 2023;165:1367-1399.
     PubMed     Abstract available
     
     
     
111. SEGAL JP
     Vedolizumab Earning Its Place as a Treatment for Chronic Pouchitis.
     Gastroenterology. 2023;165:1574-1575.
     PubMed    
     
     
     November 2023
112. KOTLARZ DANIEL
     Unveiling the protective role of BTNL-selected gammadelta T cells in inflammatory bowel disease.
     Gastroenterology. 2023 Nov 28:S0016-5085(23)05566.
     PubMed    
     
     
     
113. DAVE M, Luther J, Briggs F
     Time to Include Inflammatory Bowel Disease as a Notifiable Disease?
     Gastroenterology. 2023 Nov 7:S0016-5085(23)05223.
     PubMed    
     
     
     
114. WINE E
     Could gut and food-derived yeast be responsible for activating T-cells in Crohn disease?
     Gastroenterology. 2023 Nov 3:S0016-5085(23)05204.
     PubMed    
     
     
     
115. VENKATESWARAN N
     Mirikizumab for the Management of Ulcerative Colitis.
     Gastroenterology. 2023 Nov 3:S0016-5085(23)05206.
     PubMed    
     
     
     October 2023
116. LEE HH, Singh S
     Quantifying Endoscopic Activity in Ulcerative Colitis: Innovation, Powered by AI.
     Gastroenterology. 2023 Oct 30:S0016-5085(23)05201.
     PubMed    
     
     
     
117. STIDHAM RW, Cai L, Cheng S, Rajaei F, et al
     Using Computer Vision to Improve Endoscopic Disease Quantification in Therapeutic Clinical Trials of Ulcerative Colitis.
     Gastroenterology. 2023 Oct 11:S0016-5085(23)05086.
     PubMed     Abstract available
     
     
     
118. YARUR AJ, Bruss A, Moosreiner A, Beniwal-Patel P, et al
     Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study.
     Gastroenterology. 2023;165:963-975.
     PubMed     Abstract available
     
     
     September 2023
119. CHEN J, Yang Q, Wang C
     Multiple Hepatic Masses in a Patient with Crohn's disease.
     Gastroenterology. 2023 Sep 20:S0016-5085(23)05014.
     PubMed    
     
     
     
120. KHANNA R
     Upadacitinib for the Treatment of Crohn's Disease.
     Gastroenterology. 2023 Sep 13:S0016-5085(23)05001.
     PubMed    
     
     
     
121. GANAPATHY A, Navale P, Mutch MG, Kim H, et al
     Long-Standing Symptomatic Fistulizing Perianal Crohn's Disease: Progression beyond inflammation.
     Gastroenterology. 2023 Sep 12:S0016-5085(23)04997.
     PubMed    
     
     
     
122. LI Z, Chen Y, Ke H
     Investigating the Causal Relationship between Gut Microbiota and Crohn's Disease: A Mendelian Randomization Study.
     Gastroenterology. 2023 Sep 5:S0016-5085(23)04972.
     PubMed    
     
     
     
123. HUANG J, Chan SC, Fung YC, Mak FY, et al
     Incidence, Risk Factors, and Temporal Trends of Small Intestinal Cancer: A Global Analysis of Cancer Registries.
     Gastroenterology. 2023;165:600-612.
     PubMed     Abstract available
     
     
     
124. WINE E
     Pharmacomicrobiomics in IBD: Should We Select Treatments Based on Gut Microbes?
     Gastroenterology. 2023;165:802-803.
     PubMed    
     
     
     August 2023
125. PEYRIN-BIROULET L, Allegretti JR, Rubin DT, Bressler B, et al
     Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study.
     Gastroenterology. 2023 Aug 31:S0016-5085(23)04963.
     PubMed     Abstract available
     
     
     
126. LELEIKO NS
     Comment Regarding "Comparative Effectiveness of Anti-TNF in Combination With Low-Dose Methotrexate vs Anti-TNF Monotherapy in Pediatric Crohn's Disease: A Pragmatic Randomized Trial".
     Gastroenterology. 2023 Aug 7:S0016-5085(23)04882.
     PubMed    
     
     
     
127. KELM M, Flemming S
     Surgical Resection Might Be the Preferred Therapy Option in Ileocecal Crohn's Disease.
     Gastroenterology. 2023 Aug 4:S0016-5085(23)04840.
     PubMed    
     
     
     
128. DAMAS OM, Maldonado-Contreras A
     Breaking Barriers in Dietary Research: Strategies to Diversify Recruitment in Clinical Studies and Develop Culturally Tailored Diets for Hispanic Communities Living With Inflammatory Bowel Disease.
     Gastroenterology. 2023;165:324-328.
     PubMed    
     
     
     July 2023
129. MUKHERJEE PK, Nguyen QT, Li J, Zhao S, et al
     Stricturing Crohn's disease single-cell RNA sequencing reveals fibroblast heterogeneity and intercellular interactions.
     Gastroenterology. 2023 Jul 26:S0016-5085(23)04788.
     PubMed     Abstract available
     
     
     
130. LEWIS JD, Parlett LE, Jonsson-Funk ML, Brensinger C, et al
     Incidence, Prevalence and Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States.
     Gastroenterology. 2023 Jul 15:S0016-5085(23)04776.
     PubMed     Abstract available
     
     
     
131. BAUMDICK ME, Niehrs A, Degenhardt F, Schwerk M, et al
     HLA-DP on Epithelial Cells enables Tissue Damage by NKp44(+) NK Cells in Ulcerative Colitis.
     Gastroenterology. 2023 Jul 14:S0016-5085(23)04772.
     PubMed     Abstract available
     
     
     
132. YAN F, Yang Y
     First line treatment options for ileocecal Crohn's disease: Early surgical resection or Biologics?
     Gastroenterology. 2023 Jul 3:S0016-5085(23)00933.
     PubMed    
     
     
     
133. DEEPAK P, Barnes EL, Shaukat A
     Health Disparities in Inflammatory Bowel Disease Care Driven by Rural Versus Urban Residence: Challenges and Potential Solutions.
     Gastroenterology. 2023;165:11-15.
     PubMed    
     
     
     
134. GHUSN W, Acosta A, Kane S
     An Unusual Etiology of Bleeding in an Inflammatory Bowel Disease Surveillance Colonoscopy.
     Gastroenterology. 2023;165:40-43.
     PubMed    
     
     
     June 2023
135. GAO S, Zhu R, Zhu L
     Toward the understanding of altered gut microbiome in Crohn's disease: cause or consequence.
     Gastroenterology. 2023 Jun 23:S0016-5085(23)00883.
     PubMed    
     
     
     
136. AGRAWAL M, Ebert AC, Poulsen G, Ungaro RC, et al
     Early ileocecal resection for Crohn's disease is associated with improved long-term outcomes compared to anti-tumor necrosis factor therapy: a population-based cohort study.
     Gastroenterology. 2023 Jun 9:S0016-5085(23)00872.
     PubMed     Abstract available
     
     
     
137. HE S, Lei P, Kang W, Cheung P, et al
     Stiffness Restricts the Stemness of the Intestinal Stem Cells and Skews Their Differentiation Toward Goblet Cells.
     Gastroenterology. 2023;164:1137-1151.
     PubMed     Abstract available
     
     
     
138. ROSHANOV PS, Khanna R
     Continuation of Tumor Necrosis Factor Antagonists for Inflammatory Bowel Diseases During Pregnancy.
     Gastroenterology. 2023;164:1336-1337.
     PubMed    
     
     
     
139. KILINCALP S, Mottacki N
     A Shallow Large Ulcer on the Ileocecal Valve in a Young Man With Ulcerative Proctitis.
     Gastroenterology. 2023;164:e16-e18.
     PubMed    
     
     
     May 2023
140. RAYGOZA GARAY JA, Turpin W, Lee SH, Smith MI, et al
     Gut Microbiome Composition is associated with future onset of Crohn's Disease in Healthy First-Degree Relatives.
     Gastroenterology. 2023 May 30:S0016-5085(23)00805.
     PubMed     Abstract available
     
     
     
141. GHONEIM S
     Etrasimod in ulcerative colitis.
     Gastroenterology. 2023 May 11:S0016-5085(23)00725.
     PubMed    
     
     
     
142. ARMSTRONG H, Sigall-Boneh R, Wine E
     This Letter to the Editor is in response to: Microbial Riboflavin Biosynthesis Associates with Response to Dietary Fiber Consumption: Time to Personalize Adjunct Therapy in Patients with Inflammatory Bowel Disease?
     Gastroenterology. 2023 May 5:S0016-5085(23)00700.
     PubMed    
     
     
     
143. NEWMAN KL, Chedid VG, Boden EK
     A Systematic Review of Inflammatory Bowel Disease Epidemiology and Health Outcomes in Sexual and Gender Minority Individuals.
     Gastroenterology. 2023;164:866-871.
     PubMed    
     
     
     April 2023
144. NOBLE AJ, Nowak JK, Adams AT, Uhlig HH, et al
     Defining interactions between the genome, epigenome, and the environment in inflammatory bowel disease: progress and prospects.
     Gastroenterology. 2023 Apr 14:S0016-5085(23)00619.
     PubMed     Abstract available
     
     
     
145. D'HAENS GR, Lee S, Taylor SA, Serone A, et al
     Filgotinib for the Treatment of Small Bowel Crohn's Disease: the DIVERGENCE 1 Trial.
     Gastroenterology. 2023 Apr 11:S0016-5085(23)00591.
     PubMed    
     
     
     
146. ALLEGRETTI JR, Mitsialis V, Canavan JB, Snapper SB, et al
     Low-dose IL-2 for the Treatment of Moderate to Severe Ulcerative Colitis.
     Gastroenterology. 2023 Apr 6:S0016-5085(23)00584.
     PubMed    
     
     
     
147. FRAISSENON A, Desmurs-Clavel H, Guibaud L
     Severe Chronic Rectocolitis Associated With a Characteristic Sunflower Magnetic Resonance Imaging Pattern.
     Gastroenterology. 2023;164:529-532.
     PubMed    
     
     
     
148. GOWEN R, Gamal A, Di Martino L, McCormick TS, et al
     Modulating the Microbiome for Crohn's Disease Treatment.
     Gastroenterology. 2023;164:828-840.
     PubMed     Abstract available
     
     
     March 2023
149. KAPPELMAN MD, Wohl DA, Herfarth HH, Firestine AM, et al
     Comparative Effectiveness of Anti-TNF in Combination with Low Dose Methotrexate vs Anti-TNF Monotherapy in Pediatric Crohn's Disease: a Pragmatic Randomized Trial.
     Gastroenterology. 2023 Mar 31:S0016-5085(23)00538.
     PubMed     Abstract available
     
     
     
150. YANG Z, Qin J, Zhao L, Chen T, et al
     Host sorbitol and bacterial sorbitol utilization promote C. difficile infection in inflammatory bowel disease.
     Gastroenterology. 2023 Mar 8:S0016-5085(23)00238.
     PubMed     Abstract available
     
     
     
151. IACUCCI M, Parigi TL, Del Amor R, Meseguer P, et al
     Artificial Intelligence enabled histological prediction of remission or activity and clinical outcomes in ulcerative colitis.
     Gastroenterology. 2023 Mar 3:S0016-5085(23)00216.
     PubMed     Abstract available
     
     
     
152. NOVIELLO D, Facciotti F, Caprioli F
     Environmental Protective and Risk Factors in an At-Risk Population of Subsequent Crohn's Disease.
     Gastroenterology. 2023;164:500-501.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.